Commentary: Dopaminergic dysfunction in DYT1 dystonia

Experimental Neurology

Volumn 212, Issue 2, 2008, Pages 242-246

  Wichmann, Thomas ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

ARTICLE; BRAIN DYSFUNCTION; CLINICAL FEATURE; DISEASE MODEL; DOPAMINERGIC ACTIVITY; DOPAMINERGIC DYSFUNCTION; EVIDENCE BASED MEDICINE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; TORSION DYSTONIA;

EID: 47349110132     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.04.020     Document Type: Note

References (92)

1. Arbuthnott G.W., Ingham C.A., and Wickens J.R. Dopamine and synaptic plasticity in the neostriatum. J. Anat. 196 Pt 4 (2000) 587-596
2. Asanuma K., Ma Y., Okulski J., Dhawan V., Chaly T., Carbon M., Bressman S.B., and Eidelberg D. Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 64 (2005) 347-349
3. Augood S.J., Hollingsworth Z., Albers D.S., Yang L., Leung J., Breakefield X.O., and Standaert D.G. Dopamine transmission in DYT1 dystonia. Adv. Neurol. 94 (2004) 53-60
4. Augood S.J., Hollingsworth Z., Albers D.S., Yang L., Leung J.C., Muller B., Klein C., Breakefield X.O., and Standaert D.G. Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology 59 (2002) 445-448
5. Augood S.J., Martin D.M., Ozelius L.J., Breakefield X.O., Penney Jr. J.B., and Standaert D.G. Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain. Ann. Neurol. 46 (1999) 761-769
6. Augood S.J., Penney Jr. J.B., Friberg I.K., Breakefield X.O., Young A.B., Ozelius L.J., and Standaert D.G. Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann. Neurol. 43 (1998) 669-673
7. Balcioglu A., Kim M.O., Sharma N., Cha J.H., Breakefield X.O., and Standaert D.G. Dopamine release is impaired in a mouse model of DYT1 dystonia. J. Neurochem. 102 (2007) 783-788
8. Bandmann O., Daniel S., Marsden C.D., Wood N.W., and Harding A.E. The GTP-cyclohydrolase I gene in atypical parkinsonian patients: a clinico-genetic study. J. Neurol. Sci. 141 (1996) 27-32
9. Bateman D.N., Rawlins M.D., and Simpson J.M. Extrapyramidal reactions with metoclopramide. Br. Med. J. (Clin Res Ed) 291 (1985) 930-932
10. Berardelli A., Rothwell J.C., Hallett M., Thompson P.D., Manfredi M., and Marsden C.D. The pathophysiology of primary dystonia. Brain 121 (1998) 1195-1212
11. Black K.J., Gado M.H., and Perlmutter J.S. PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function. J. Neurosci. 17 (1997) 3168-3177
12. Brashear A., Mulholland G.K., Zheng Q.H., Farlow M.R., Siemers E.R., and Hutchins G.D. PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP). Mov. Disord. 14 (1999) 132-137
13. Bressman S.B. Dystonia genotypes, phenotypes, and classification. Adv. Neurol. 94 (2004) 101-107
14. Bressman S.B., de Leon D., Brin M.F., Risch N., Burke R.E., Greene P.E., Shale H., and Fahn S. Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance. Ann. Neurol. 26 (1989) 612-620
15. Bruno J.P., Sandstrom M.I., Arnold H.M., and Nelson C.L. Age-dependent neurobehavioral plasticity following forebrain dopamine depletions. Dev. Neurosci. 20 (1998) 164-179
16. Bruno M.K., Ravina B., Garraux G., Hallett M., Ptacek L., Singleton A., Johnson J., Hanson M., Considine E., and Gwinn-Hardy K. Exercise-induced dystonia as a preceding symptom of familial Parkinson's disease. Mov. Disord. 19 (2004) 228-230
17. Burke R.E., Fahn S., Jankovic J., Marsden C.D., Lang A.E., Gollomp S., and Ilson J. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 32 (1982) 1335-1346
18. Burke R.E., Reches A., Traub M.M., Ilson J., Swash M., and Fahn S. Tetrabenazine induces acute dystonic reactions. Ann. Neurol. 17 (1985) 200-202
19. Casey D.E. Pathophysiology of antipsychotic drug-induced movement disorders. J. Clin. Psychiatry 65 Suppl 9 (2004) 25-28
20. Dang M.T., Yokoi F., McNaught K.S., Jengelley T.A., Jackson T., Li J., and Li Y. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp. Neurol. 196 (2005) 452-463
21. Dang M.T., Yokoi F., Pence M.A., and Li Y. Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci. Res. 56 (2006) 470-474
22. Day M., Wang Z., Ding J., An X., Ingham C.A., Shering A.F., Wokosin D., Ilijic E., Sun Z., Sampson A.R., Mugnaini E., Deutch A.Y., Sesack S.R., Arbuthnott G.W., and Surmeier D.J. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci. 9 (2006) 251-259
23. Duvoisin R.C., Yahr M.D., Lieberman J., Antunes J., and Rhee S. The striatal foot. Trans. Am. Neurol. Assoc. 97 (1974) 267
24. Ernst M., Zametkin A.J., Matochik J.A., Pascualvaca D., Jons P.H., Hardy K., Hankerson J.G., Doudet D.J., and Cohen R.M. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N. Engl. J. Med. 334 (1996) 1568-1572
25. Fabbrini G., Brotchie J.M., Grandas F., Nomoto M., and Goetz C.G. Levodopa-induced dyskinesias. Mov. Disord. 22 (2007) 1379-1389 quiz 1523
26. Factor S.A., and Matthews M.K. Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapy. South. Med. J. 84 (1991) 626-628
27. Furukawa Y., Hornykiewicz O., Fahn S., and Kish S.J. Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology 54 (2000) 1193-1195
28. Gershanik O.S. Drug-induced dyskinesias. In: Jankovic J., and Tolosa E. (Eds). Parkinson's Disease and Movement Disorders. 3rd edition (1998), Williams & Wilkins, Baltimore 579-600
29. Goldstein S.R., Matsumoto R.R., Thompson T.L., Patrick R.L., Bowen W.D., and Walker J.M. Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons. Synapse 4 (1989) 254-258
30. Gonzalez-Alegre P., and Paulson H.L. Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia. J. Neurosci. 24 (2004) 2593-2601
31. Goodchild R.E., and Dauer W.T. Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 847-852
32. Goodchild R.E., Kim C.E., and Dauer W.T. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron. 48 (2005) 923-932
33. Grundmann K., Reischmann B., Vanhoutte G., Hubener J., Teismann P., Hauser T.K., Bonin M., Wilbertz J., Horn S., Nguyen H.P., Kuhn M., Chanarat S., Wolburg H., Van der Linden A., and Riess O. Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol. Dis. 27 (2007) 190-206
34. Hallett M. Bromocriptine for levodopa-induced end-of-dose dystonia. Lancet 1 (1981) 616
35. Hewett J., Gonzalez-Agosti C., Slater D., Ziefer P., Li S., Bergeron D., Jacoby D.J., Ozelius L.J., Ramesh V., and Breakefield X.O. Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum. Mol. Genet. 9 (2000) 1403-1413
36. Hewett J., Ziefer P., Bergeron D., Naismith T., Boston H., Slater D., Wilbur J., Schuback D., Kamm C., Smith N., Camp S., Ozelius L.J., Ramesh V., Hanson P.I., and Breakefield X.O. TorsinA in PC12 cells: localization in the endoplasmic reticulum and response to stress. J. Neurosci. Res. 72 (2003) 158-168
37. Hewett J.W., Tannous B., Niland B.P., Nery F.C., Zeng J., Li Y., and Breakefield X.O. Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 7271-7276
38. Hornykiewicz O. Chemical neuroanatomy of the basal ganglia-normal and in Parkinson's disease. J. Chem. Neuroanat. 22 (2001) 3-12
39. Ichinose H., Ohye T., Takayashi E., Seki N., Hori T., Segawa M., Nomura Y., Endo K., Tanaka H., and Tsuji S. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat. Genet. 8 (1994) 236-242
40. Ingham C.A., Hood S.H., Taggart P., and Arbuthnott G.W. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J. Neurosci. 18 (1998) 4732-4743
41. Jankovic J. Dystonia and other deformities in Parkinson's disease. J. Neurol. Sci. 239 (2005) 1-3
42. Joyce J.N., Frohna P.A., and Neal-Beliveau B.S. Functional and molecular differentiation of the dopamine system induced by neonatal denervation. Neurosci. Biobehav. Rev. 20 (1996) 453-486
43. Kang U.J., Burke R.E., and Fahn S. Tardive dystonia. Adv. Neurol. 50 (1988) 415-429
44. Katzenschlager R., Costa D., Gacinovic S., and Lees A.J. [(123)I]-FP-CIT-SPECT in the early diagnosis of PD presenting as exercise-induced dystonia. Neurology 59 (2002) 1974-1976
45. Klein C., Brin M.F., Kramer P., Sena-Esteves M., de Leon D., Doheny D., Bressman S., Fahn S., Breakefield X.O., and Ozelius L.J. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5173-5176
46. Knappskog P.M., Flatmark T., Mallet J., Ludecke B., and Bartholome K. Recessively inherited l-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 4 (1995) 1209-1212
47. Konakova M., Huynh D.P., Yong W., and Pulst S.M. Cellular distribution of torsin A and torsin B in normal human brain. Arch. Neurol. 58 (2001) 921-927
48. Kontur P.J., al-Tikriti M., Innis R.B., and Roth R.H. Postmortem stability of monoamines, their metabolites, and receptor binding in rat brain regions. J. Neurochem. 62 (1994) 282-290
49. Kramer P.L., de Leon D., Ozelius L., Risch N., Bressman S.B., Brin M.F., Schuback D.E., Burke R.E., Kwiatkowski D.J., Shale H., et al. Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34. Ann. Neurol. 27 (1990) 114-120
50. Liu Z., Zolkiewska A., and Zolkiewski M. Characterization of human torsinA and its dystonia-associated mutant form. Biochem. J. 374 (2003) 117-122
51. McNaught K.S., Kapustin A., Jackson T., Jengelley T.A., Jnobaptiste R., Shashidharan P., Perl D.P., Pasik P., and Olanow C.W. Brainstem pathology in DYT1 primary torsion dystonia. Ann. Neurol. 56 (2004) 540-547
52. Misbahuddin A., Placzek M.R., Taanman J.W., Gschmeissner S., Schiavo G., Cooper J.M., and Warner T.T. Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells. Mov. Disord. 20 (2005) 432-440
53. Nagatsu T., and Ichinose H. GTP cyclohydrolase I gene, dystonia, juvenile parkinsonism, and Parkinson's disease. J. Neural. Transm., Suppl. 49 (1997) 203-209
54. Naismith T.V., Heuser J.E., Breakefield X.O., and Hanson P.I. TorsinA in the nuclear envelope. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7612-7617
55. Naumann M., Pirker W., Reiners K., Lange K.W., Becker G., and Brucke T. Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT. Mov. Disord. 13 (1998) 319-323
56. Nausieda P.A., Weiner W.J., and Klawans H.L. Dystonic foot response of Parkinsonism. Arch. Neurol. 37 (1980) 132-136
57. Nemeth A.H. The genetics of primary dystonias and related disorders. Brain 125 (2002) 695-721
58. Nutt J.G., Muenter M.D., Aronson A., Kurland L.T., and Melton III L.J. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov. Disord. 3 (1988) 188-194
59. Nygaard T.G. Dopa-responsive dystonia. Curr. Opin. Neurol. 8 (1995) 310-313
60. Ozelius L., Kramer P.L., Moskowitz C.B., Kwiatkowski D.J., Brin M.F., Bressman S.B., Schuback D.E., Falk C.T., Risch N., de Leon D., et al. Human gene for torsion dystonia located on chromosome 9q32-q34. Neuron 2 (1989) 1427-1434
61. Ozelius L.J., Hewett J.W., Page C.E., Bressman S.B., Kramer P.L., Shalish C., de Leon D., Brin M.F., Raymond D., Corey D.P., Fahn S., Risch N.J., Buckler A.J., Gusella J.F., and Breakefield X.O. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 17 (1997) 40-48
62. Ozelius L.J., Kramer P.L., de Leon D., Risch N., Bressman S.B., Schuback D.E., Brin M.F., Kwiatkowski D.J., Burke R.E., Gusella J.F., et al. Strong allelic association between the torsion dystonia gene (DYT1) andloci on chromosome 9q34 in Ashkenazi Jews. Am. J. Hum. Genet. 50 (1992) 619-628
63. Patel K., Roskrow T., Davis J.S., and Heckmatt J.Z. Dopa responsive dystonia. Arch. Dis. Child. 73 (1995) 256-257
64. Perlmutter J.S., and Mink J.W. Dysfunction of dopaminergic pathways in dystonia. Adv. Neurol. 94 (2004) 163-170
65. 18F]spiperone binding in putamen in idiopathic focal dystonia. J. Neurosci. 17 (1997) 843-850
66. Perlmutter J.S., Tempel L.W., Black K.J., Parkinson D., and Todd R.D. MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia. Neurology 49 (1997) 1432-1438
67. Pinninti N.R., Mago R., and Adityanjee. Tardive dystonia-associated prescription of aripiprazole. J. Neuropsychiatry Clin. Neurosci. 18 (2006) 426-427
68. Pisani A., Martella G., Tscherter A., Bonsi P., Sharma N., Bernardi G., and Standaert D.G. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol. Dis. 24 (2006) 318-325
69. Placzek M.R., Misbahuddin A., Chaudhuri K.R., Wood N.W., Bhatia K.P., and Warner T.T. Cervical dystonia is associated with a polymorphism in the dopamine (D5) receptor gene. J. Neurol. Neurosurg. Psychiatry 71 (2001) 262-264
70. Playford E.D., Fletcher N.A., Sawle G.V., Marsden C.D., and Brooks D.J. Striatal [18F]dopa uptake in familial idiopathic dystonia. Brain 116 (1993) 1191-1199
71. Purves-Stewart J. Paralysis agitans with an account of a new symptom. Lancet 2 (1898) 1258-1260
72. Risch N.J., Bressman S.B., deLeon D., Brin M.F., Burke R.E., Greene P.E., Shale H., Claus E.B., Cupples L.A., and Fahn S. Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. Am. J. Hum. Genet. 46 (1990) 533-538
73. Rostasy K., Augood S.J., Hewett J.W., Leung J.C., Sasaki H., Ozelius L.J., Ramesh V., Standaert D.G., Breakefield X.O., and Hedreen J.C. TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol. Dis. 12 (2003) 11-24
74. Rupniak N.M., Jenner P., and Marsden C.D. Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berl) 88 (1986) 403-419
75. Sharma N., Baxter M.G., Petravicz J., Bragg D.C., Schienda A., Standaert D.G., and Breakefield X.O. Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J. Neurosci. 25 (2005) 5351-5355
76. Sharma N., Hewett J., Ozelius L.J., Ramesh V., McLean P.J., Breakefield X.O., and Hyman B.T. A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study. Am. J. Pathol. 159 (2001) 339-344
77. Shashidharan P., Kramer B.C., Walker R.H., Olanow C.W., and Brin M.F. Immunohistochemical localization and distribution of torsinA in normal human and rat brain. Brain Res. 853 (2000) 197-206
78. Shashidharan P., Sandu D., Potla U., Armata I.A., Walker R.H., McNaught K.S., Weisz D., Sreenath T., Brin M.F., and Olanow C.W. Transgenic mouse model of early-onset DYT1 dystonia. Hum. Mol. Genet. 14 (2005) 125-133
79. Spokes E.G. An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue. Brain 102 (1979) 333-346
80. Starr P.A., Rau G.M., Davis V., Marks Jr. W.J., Ostrem J.L., Simmons D., Lindsey N., and Turner R.S. Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's disease and normal macaque. J. Neurophysiol. 93 (2005) 3165-3176
81. Suzuki M., Hirai T., Ito Y., Sakamoto T., Oka H., Kurita A., and Inoue K. Pramipexole-induced antecollis in Parkinson's disease. J. Neurol. Sci. 264 (2008) 195-197
82. Tabbal S.D., Mink J.W., Antenor J.A., Carl J.L., Moerlein S.M., and Perlmutter J.S. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine. Neuroscience 141 (2006) 1281-1287
83. Tolosa E., and Compta Y. Dystonia in Parkinson's disease. J Neurol 253 Suppl 7 (2006) VII7-VII13
84. Uncini A., De Angelis M.V., Di Fulvio P., Ragno M., Annesi G., Filla A., Stuppia L., and Gambi D. Wide expressivity variation and high but no gender-related penetrance in two dopa-responsive dystonia families with a novel GCH-I mutation. Mov. Disord. 19 (2004) 1139-1145
85. Van Hove J.L., Steyaert J., Matthijs G., Legius E., Theys P., Wevers R., Romstad A., Moller L.B., Hedrich K., Goriounov D., Blau N., Klein C., and Casaer P. Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J. Neurol. Neurosurg. Psychiatry 77 (2006) 18-23
86. Visser J.E., Bar P.R., and Jinnah H.A. Lesch-Nyhan disease and the basal ganglia. Brain Res. Brain Res. Rev. 32 (2000) 449-475
87. Visser J.E., Harris J.C., Barabas G., Eddey G.E., and Jinnah H.A. The motor disorder of classic Lesch-Nyhan disease. Nucleosides Nucleotides Nucleic Acids 23 (2004) 1161-1164
88. Vitek J.L., Zhang J., Evatt M., Mewes K., DeLong M.R., Hashimoto T., Triche S., and Bakay R.A.E. GPi pallidotomy for dystonia: clinical outcome and neuronal activity. In: Fahn S., Marsden C.D., and DeLong M.R. (Eds). Dystonia 3 (1998), Lippincott-Raven, Philadelphia 211-220
89. Walker R.H., Brin M.F., Sandu D., Good P.F., and Shashidharan P. TorsinA immunoreactivity in brains of patients with DYT1 and non-DYT1 dystonia. Neurology 58 (2002) 120-124
90. Wong D.F., Harris J.C., Naidu S., Yokoi F., Marenco S., Dannals R.F., Ravert H.T., Yaster M., Evans A., Rousset O., Bryan R.N., Gjedde A., Kuhar M.J., and Breese G.R. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5539-5543
91. Zhao Y., DeCuypere M., and LeDoux M.S. Abnormal motor function and dopamine neurotransmission in DYT1 ΔGAG transgenic mice. Exp. Neurol. 210 (2008) 719-730
92. Zweig R.M., Hedreen J.C., Jankel W.R., Casanova M.F., Whitehouse P.J., and Price D.L. Pathology in brainstem regions of individuals with primary dystonia. Neurology 38 (1988) 702-706